University of South Alabama - Mitchell Cancer Institute — Mobile, Alabama

University of South Alabama - Mitchell Cancer Institute is a clinical research site located in Mobile, Alabama, United States 36604.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of South Alabama - Mitchell Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer, Hodgkin Disease, Peripheral T Cell Lymphoma.

Sponsors: Seagen Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Alabama - Mitchell Cancer Institute?

University of South Alabama - Mitchell Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Alabama - Mitchell Cancer Institute conducted?

University of South Alabama - Mitchell Cancer Institute has 2 clinical trials on record. Their work covers HER2 Positive Breast Cancer, Hodgkin Disease, Peripheral T Cell Lymphoma.

Is University of South Alabama - Mitchell Cancer Institute accredited by Crixeo Health?

University of South Alabama - Mitchell Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Alabama - Mitchell Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.